Description: "This session will cover recent and new NAIC actuarial guidelines and their impact on U.S. statutory cash flow testing. The focus will be on the new Reinsurance Asset Adequacy Testing Actuarial Guideline and Actuarial Guideline 53. It is intended to benefit consultants interacting with NAIC statutory regulations, including those involved in appointed actuary work, statutory financial reporting, or mergers and acquisitions."

Description: This webcast will explore the shifting landscape of healthcare costs. It will cover healthcare trend basics, recent developments, and what’s ahead. Drawing from comprehensive data analysis and industry insights, this presentation promises to equip attendees with actionable knowledge to navigate the complex terrain of healthcare expenses effectively.

Description: This session will cover the latest information on annuity products. It will cover sales levels, product features, and pricing trends. It will also cover latest regulation effects on products and pricing. It will give the audience a well-rounded view of the annuity market and the current environment.

Description: Artificial intelligence is rapidly transforming the investment landscape. From natural language processing and large language models to physical AI applications like robotics, autonomous vehicles, and drones, the evolution of AI is reshaping both how we analyze data and where we find opportunity. We’ll begin by exploring the evolution of AI, which is already driving disruption across industries such as coding, customer service, and marketing. However, the future of AI is physical AI (drones, AVs, robotics). With valuations already stretched, and growing concerns about the “circular economy” and bubble risks, investors should focus on high-quality tech companies that generate free cash flow and deliver strong returns on invested capital. We'll explore examples of interesting companies across the globe: Meta, Alphabet, and Uber in the US; ASML in Europe; Tokyo Electron in Japan; TSMC in Taiwan; and BYD in China. The session will also examine how natural language processing and large language models are reshaping the way quantitative and fundamental managers extract insights from raw data. We’ll highlight how these tools are being deployed to enhance understanding of risk and return, and how they’re increasingly supporting collaboration between quant and fundamental teams.

Description: Worried about the latest wildfires? Can't keep up with the latest geopolitical landscape? Wondering how close AI is to taking over? Join us as we discuss the results of the 18th edition of the Emerging Risk Survey. This is an annual survey which is jointly sponsored by the Casualty Actuarial Society and the Society of Actuaries Research Institute.

Description: Learn about key topics affecting actuaries working in the dental insurance space! The session will include valuable information for health actuaries looking to better understand how dental fits into Medicaid, Medicare, commercial, and ACA markets.

Description: "Hear an overview of recent results and potential scenarios that may impact the future of the ACA market. Review recent reported industry level profitability before transitioning to a discussion of how current market dynamics may influence the future profitability of this segment. Results from microsimulation economic models will be presented to help illuminate market shifts. Issues that will be explored include how ICRA availability might influence individual decision making, as well as how a move to level funding is impacting the small group market. By attending this session, you will: Understand the recent average and variation of industry performance in the ACA market segment. Describe current policy and market forces that are expected to impact this segment. Explain the range of market scenarios that may result due to these forces."

Description: In this session, presenters will share the impacts of transition to IFRS 17 on equity and various KPIs across insurance companies (Life & P&C), as well as share some observations of what the IFRS 17 landscape looks like across different global regions. The session will conclude with lessons learned and expectations for emerging practices under IFRS 17 globally.

Description: Join this presentation covering the key provisions of the IRA which govern the selection of drugs for negotiation. We will also discuss what these changes mean for all Medicare Part D stakeholders, including: Government Beneficiary Part D Plans Drug Manufacturers Original Content:

Description: Come explore an in-depth overview of telehealth to set context and navigate the continuing expansion of telehealth and its integration into the healthcare delivery system. You will examine the forces that shape telehealth offerings and expect a view of the possible futures of this evolving modality.